Concepedia

Noriko Ueyama

NU

Statistics

Publications

5

Citations

295

H-Index

5

Active since

2002

Affiliations

Mochida Pharmaceutical (Japan)(Current)

Osaka Neurological Institute

Fujisawa City Hospital

Noriko Ueyama is an author at Mochida Pharmaceutical (Japan) specializing in pharmacology, medicine, and rodent cerebral ischemia.

Publications per year

2002–2004

5

Publications

5

Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils

Kiyotaka Katsuta, Kazuo Umemura, Noriko Ueyama et al. · European Journal of Pharmacology · 2003 · 80 citations · Full text

, , +14

Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors

Takuya Maemoto, Miho Tada, Takuma Mihara et al. · Journal of Pharmacological Sciences · 2004 · 79 citations · Full text

, , +11

Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy

Yasuhisa Furuichi, Kiyotaka Katsuta, Masashi Maeda et al. · Brain Research · 2003 · 74 citations

, , +17

A Combined Treatment with Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

Masashi Maeda, Yasuhisa Furuichi, Noriko Ueyama et al. · Journal of Cerebral Blood Flow & Metabolism · 2002 · 41 citations · Full text

, , +17

A Combined Treatment With Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

Masashi Maeda, Yasuhisa Furuichi, Noriko Ueyama et al. · Journal of Cerebral Blood Flow & Metabolism · 2002 · 21 citations

, , +17

1–5 of 5